| 000 | 01730 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517195231.0 | ||
| 264 | 0 | _c20180927 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1432-2277 | ||
| 024 | 7 |
_a10.1111/tri.13112 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBielen, Rob | |
| 245 | 0 | 0 |
_aPersonalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study. _h[electronic resource] |
| 260 |
_bTransplant international : official journal of the European Society for Organ Transplantation _c05 2018 |
||
| 300 |
_a503-509 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDNA, Viral _xanalysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B _xprevention & control |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRenal Insufficiency _xprevention & control |
| 700 | 1 | _aRobaeys, Geert | |
| 700 | 1 | _aSchelfhout, Sigrid | |
| 700 | 1 | _aMonbaliu, Diethard | |
| 700 | 1 | _aVan der Merwe, Schalk | |
| 700 | 1 | _aPirenne, Jacques | |
| 700 | 1 | _aNevens, Frederik | |
| 773 | 0 |
_tTransplant international : official journal of the European Society for Organ Transplantation _gvol. 31 _gno. 5 _gp. 503-509 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/tri.13112 _zAvailable from publisher's website |
| 999 |
_c28005197 _d28005197 |
||